ACELLERA THERAPEUTICS Trademark
Trademark Overview
On Wednesday, June 14, 2023, a trademark application was filed for ACELLERA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ACELLERA THERAPEUTICS trademark a serial number of 98041664. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, October 4, 2024. This trademark is owned by ACELLERA THERAPEUTICS, INC.. The ACELLERA THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:
Computer hardware and recorded software systems for use in molecular research; computer software for use in the research and development of pharmaceutical products, for the analysis of biological and chemical activity, for the design of chemical structures; computer software for cell analysis, design and development of computer hardware and computer software in the field of drug and chemical development; Downloadable computer graphics software; Imaging apparatus and instruments for use in the study of proteins and peptides in drug development
Chemical preparations for pharmaceutical or medical purposes, namely, for biochemical preparations for medical and veterinary purposes; Drug delivery agents in the form of powders that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents
Biochemical research and development; Chemistry consultation; Drug discovery services; Drug screening for scientific research purposes; Pharmaceutical research services; Product development for others; Providing medical and scientific research information; Research and development of computer software; Research and development services in connection with physics; Research in the field of physics; Biotechnology research; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Computer programming; Computer programming consultancy in the field of of drug and chemical development; Computer software consultancy; Computer software design; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Design of computer-simulated models; Pharmaceutical drug development services; Pharmaceutical research and develop...
General Information
| Serial Number | 98041664 |
| Word Mark | ACELLERA THERAPEUTICS |
| Filing Date | Wednesday, June 14, 2023 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Friday, October 4, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of a stylized white letter "A" situated inside a blue shaded oval. To the right of the design appears stylized blue wording "ACELLERA" situated on top of the stylized blue wording "THERAPEUTICS". |
| Goods and Services | Computer hardware and recorded software systems for use in molecular research; computer software for use in the research and development of pharmaceutical products, for the analysis of biological and chemical activity, for the design of chemical structures; computer software for cell analysis, design and development of computer hardware and computer software in the field of drug and chemical development; Downloadable computer graphics software; Imaging apparatus and instruments for use in the study of proteins and peptides in drug development |
| Goods and Services | Chemical preparations for pharmaceutical or medical purposes, namely, for biochemical preparations for medical and veterinary purposes; Drug delivery agents in the form of powders that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents |
| Indication of Colors claimed | The color(s) blue and white is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Biochemical research and development; Chemistry consultation; Drug discovery services; Drug screening for scientific research purposes; Pharmaceutical research services; Product development for others; Providing medical and scientific research information; Research and development of computer software; Research and development services in connection with physics; Research in the field of physics; Biotechnology research; Chemical research; Chemical, biochemical, biological and bacteriological research and analysis; Computer programming; Computer programming consultancy in the field of of drug and chemical development; Computer software consultancy; Computer software design; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Design of computer-simulated models; Pharmaceutical drug development services; Pharmaceutical research and development; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research in the field of chemistry; Research in the field of molecular ecology; Research on the subject of pharmaceuticals; Software as a service (SAAS) services featuring software using artificial intelligence for services featuring computer software platforms for use in database management for optimizing drug and chemistry discovery; chemistry services in the nature of drug discovery services; chemical research and chemistry consultation in the field of drug and chemical development; Technical research in the field of pharmaceutical studies |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 18, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 18, 2023 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 18, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ACELLERA THERAPEUTICS, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | FREMONT, CA 94536 |
Trademark Events
| Event Date | Event Description |
| Saturday, June 17, 2023 | NEW APPLICATION ENTERED |
| Wednesday, June 21, 2023 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Wednesday, June 21, 2023 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Tuesday, July 18, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 5, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, March 19, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 19, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, March 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 17, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, June 17, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 17, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 18, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 18, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 18, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, October 4, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, October 4, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, October 4, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, October 28, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Monday, October 28, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, October 28, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, October 28, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, October 28, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, October 28, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, December 6, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, December 6, 2024 | ASSIGNED TO LIE |
